Cybersecurity Roundup: Microsoft, Stellantis, Anthropic's Mythos, Palo Alto Networks Address AI-Driven Attack Threats

• Valuasi Anthropic melonjak drastis dari $61 miliar menjadi $900 miliar dalam waktu sekitar 14 bulan, mencerminkan minat investor yang belum pernah terjadi sebelumnya terhadap kemampuan dan lintasan pertumbuhan perusahaan AI tersebut. • Lonjakan valuasi ini didorong oleh kinerja pendapatan yang kuat dan kepercayaan investor terhadap model serta riset AI Anthropic, memposisikannya sebagai pesaing tangguh bagi OpenAI di pasar AI generatif. • Kenaikan pesat ini menunjukkan persaingan modal yang semakin intensif dalam pengembangan frontier AI, dengan investor besar mendukung berbagai startup AI untuk mengantisipasi potensi transformatif teknologi ini.

• Deep Tech Week menyoroti The AI Collective, yang digambarkan sebagai komunitas AI terbesar di dunia, yang menghubungkan lebih dari 100.000 pembangun, peneliti, dan profesional AI melalui acara, forum, dan jejaring. • Pertemuan tersebut mempertemukan startup, lab korporat, dan kelompok akademis untuk memamerkan kemajuan dalam core machine learning, robotika, dan AI terapan, dengan fokus pada interoperabilitas dan penerapan yang bertanggung jawab. • Partisipasi A.S. sangat kuat, dengan banyak lab riset AI terkemuka dan venture‑backed startups menggunakan ajang ini untuk mengumumkan kolaborasi baru, perilisan model, dan open‑source tooling.

• Pada kuartal pertama tahun 2026, perusahaan teknologi asuransi berbasis AI menarik modal yang signifikan, termasuk pendanaan seed plus Seri A senilai $47 juta dari Harper Group dan Seri B senilai $50 juta dari Indigo Technologies, yang keduanya berfokus pada alur kerja underwriting dan klaim yang diotomatisasi AI. • Platform seperti Mea Platforms, Pasito, General Magic, dan Qumis mengumpulkan antara $4,3 juta hingga $50 juta untuk mengotomatisasi proses yang padat dokumen, mengurangi rasio kerugian, serta mempercepat waktu penawaran (quote) dan penerbitan polis (bind) bagi bisnis kecil dan menengah. • Investor mendukung vendor berbasis AS yang menggunakan AI untuk meningkatkan skala distribusi tanpa pertumbuhan jumlah karyawan yang proporsional, mengurangi hambatan dalam pemilihan manfaat, dan meningkatkan pemilihan risiko di lini komersial.

• Meta reported $107bn in contractual commitments for Q1 2026 cloud services to fuel AI model development. • Aggressive investments include datacenter expansions and supply chain deals for AI hardware components. • Company expects AI breakthroughs later in 2026, pushing to monetize advanced research.

• Oracle merilis advisori keamanan pelanggan baru pada 30 April 2026, guna mengantisipasi ancaman terhadap model AI. • Advisori ini menyoroti pertanda keamanan siber, mendesak pembaruan postur keamanan untuk implementasi AI. • Ini menandakan langkah-langkah proaktif terhadap kerentanan baru yang menargetkan sistem AI generatif.

• Amazon Web Services achieved its fastest growth in nearly four years, fueled by AI solutions and enterprise adoption. • Key drivers include innovations like Bedrock and Kiro amid surging cloud spending. • AI is sparking a new wave of infrastructure investments in the US market.

• SoftBank is preparing Roze AI, combining robotics, data centers, and AI infrastructure for a US IPO targeting $100B valuation. • Masayoshi Son backs the venture, with potential public listing as early as late 2026 or 2027. • Executives plan an analyst day in July, though no products or revenue plans announced yet.

• Aviatrix Inc. announced the launch of a new platform designed to contain artificial intelligence agents and enforce security controls across AI workloads without requiring changes to AI agents or code. • The platform extends Aviatrix's Cloud Native Security Fabric with two new products: Zero Trust for AI Workloads (now generally available) and Aviatrix AgentGuard (in early access), enabling IT teams to set policies that allow or deny access to external AI services and block shadow AI with allowlists. • The solution provides network-layer enforcement across workloads and regions, addressing the growing need to secure AI agents, large language model proxies, and agentic frameworks in enterprise environments.

• The Pentagon launched GenAI.mil in December 2025 as part of Project Maven, providing secure generative AI access to approximately 3 million Department of Defense staff members. • The platform embeds multiple leading AI models including Anthropic's Claude, Google's Gemini, xAI's Grok, and OpenAI's ChatGPT, enabling widespread AI adoption across military operations. • The initiative reflects the U.S. military's strategic priority to integrate advanced AI capabilities into defense operations and demonstrates significant government investment in dual-use AI technology.

• Skye AI, a home screen app for iPhone powered by artificial intelligence, raised $3.58 million in pre-seed funding while still in private testing phase. • The funding supports development of the app, which aims to enhance iPhone user experience through AI-driven features accessible directly from the home screen. • This investment highlights growing investor interest in mobile AI applications amid competition in the smartphone ecosystem.

• Sevii announced the launch of its Autonomous Cyber Swarm Defense (CSD) capability on April 28, 2026, to counter high-volume AI-driven cyber attacks at machine speed and scale. • The ADR platform deploys Agentic AI Cyber Warrior agents that detect, contain, and remediate threats in under 15 minutes, reducing analyst workloads by 95% with a fixed per-asset pricing model eliminating AI token costs. • CSD Mode features Myrmidon Defense Technology (MDT) for efficient micro-orchestration, enabling predictable budgeting without additional hires or outsourcing, as noted by Synergem Technologies CEO Frank Holt.

• Framingham, MA-based Tortugas Neuroscience raised $106 million in combined seed and Series A funding for small molecule therapies targeting neurological disorders. • Cure Ventures led the seed round, with The Column Group and AN Venture Partners co-leading Series A on April 21. • The investment accelerates development of treatments using validated biological targets, addressing unmet needs in US biotech.